Compare IMVT & SIRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMVT | SIRI |
|---|---|---|
| Founded | 2018 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Broadcasting |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5B | 10.1B |
| IPO Year | 2019 | 1996 |
| Metric | IMVT | SIRI |
|---|---|---|
| Price | $37.70 | $29.51 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 8 |
| Target Price | ★ $33.00 | $28.86 |
| AVG Volume (30 Days) | 1.1M | ★ 3.3M |
| Earning Date | 05-28-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 4.03% |
| EPS Growth | N/A | ★ 136.32 |
| EPS | N/A | ★ 1.42 |
| Revenue | N/A | ★ $5,425,129,000.00 |
| Revenue This Year | N/A | $1.81 |
| Revenue Next Year | N/A | $0.67 |
| P/E Ratio | ★ N/A | $20.53 |
| Revenue Growth | N/A | ★ 8.13 |
| 52 Week Low | $14.58 | $19.77 |
| 52 Week High | $45.42 | $32.66 |
| Indicator | IMVT | SIRI |
|---|---|---|
| Relative Strength Index (RSI) | 31.10 | 52.71 |
| Support Level | $23.66 | $29.18 |
| Resistance Level | $41.22 | $30.13 |
| Average True Range (ATR) | 1.42 | 0.66 |
| MACD | -0.66 | 0.11 |
| Stochastic Oscillator | 0.00 | 68.75 |
Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The Company operates in a single operating segment and has one reportable segment, which includes all activities related to the discovery, development and manufacturing of its product candidates.
Sirius XM operates almost exclusively in the US through its SiriusXM and Pandora audio services. SiriusXM is primarily a satellite radio service that offers nationwide coverage and mostly ad-free listening, with proprietary channels and exclusive content. It makes agreements with automakers to install its radios in vehicles and give trial services to vehicle buyers, which have traditionally fed its subscriber base. The company provides the service via a fleet of geostationary satellites it owns and operates and now offers a streaming SiriusXM option. Pandora, which accounts for a much smaller portion of revenue and profit, offers a subscription and ad-supported streaming music service that competes with industry giants such as Spotify, Apple Music, and YouTube Music.